A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TP53

Search Conditions:
Search Keyword : TP53
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TP53
Appearance Frequency: 432 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor protein p53
(324 times)
Neoplasms
(118 times)
EGFR (27 times)
KRAS (18 times)
PIK3CA (18 times)
1993 Localization of the tumour protein, TP53, on porcine chromosome 12q12-q14.
tumor suppressor p53
(32 times)
Neoplasms
(12 times)
HPV (3 times)
PCR (2 times)
SNP (2 times)
2002 Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
tumor protein p53 gene
(20 times)
Neoplasms
(15 times)
ATM (3 times)
PIK3CA (3 times)
STK11 (3 times)
2005 Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature.
tumor suppressor protein p53
(20 times)
Neoplasms
(6 times)
CI (3 times)
ATM (2 times)
OR (2 times)
1995 Assignment of three loci: tumor suppressor protein-53 (TP53), retinoic acid receptor A (RARA), collagen 1A1 (COL1A1) to Syrian hamster chromosome 9. Evidence that this chromosome is homologous with human chromosome 17, mouse chromosome 11, and rat chromosome 10.
p53 tumor suppressor gene
(7 times)
Cell Biology
(2 times)
EMSAs (1 time)
FFPE (1 time)
NSCLCs (1 time)
1998 p53 and brain tumors: from gene mutations to gene therapy.
wild-type p53 gene
(4 times)
Genetics
(1 time)
5-FU (1 time)
CRC (1 time)
PCR (1 time)
1998 p53: prospects for cancer gene therapy.
TP53wt
(2 times)
Neoplasms
(2 times)
ALL (1 time)
hyper-CVAD (1 time)
TP53mut (1 time)
2000 Raf-1 kinase activity predicts for paclitaxel resistance in TP53mut, but not TP53wt human ovarian cancer cells.
tumor antigen p53
(2 times)
Clinical Laboratory Techniques
(1 time)
EC (1 time)
PIK3CA (1 time)
SAAV (1 time)
2016 The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.
p53 tumor antigen gene
(1 time)
Genetics
(1 time)
--- 1991 Chromosomal localization of two human zinc finger protein genes, ZNF24 (KOX17) and ZNF29 (KOX26), to 18q12 and 17p13-p12, respectively.
10  Then, anti‑tumor protein53
(1 time)
Neoplasms
(1 time)
AGR3 (1 time)
HGSC (1 time)
LGSC (1 time)
2018 Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
11  three continents for p53 gene
(1 time)
Science
(1 time)
HBV (1 time)
1994 Genetic heterogeneity of hepatocellular carcinoma.
12  through stabilization of p53
(1 time)
Genetics
(1 time)
--- 2007 Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
13  TP53 and D17S786
(1 time)
Neoplasms
(1 time)
LOH (1 time)
2000 Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
14  TP53 codon 72
(1 time)
Biology
(1 time)
--- 2007 TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population.
15  TP53 frameshift mutation
(1 time)
Clinical Medicine
(1 time)
ctDNA (1 time)
2017 Rapid Changes in Circulating Tumor DNA in Serially Sampled Plasma During Treatment of Breast Cancer: A Case Report.
16  TP53.del42bp
(1 time)
Biochemistry
(1 time)
Ad (1 time)
ECa (1 time)
UPSC (1 time)
2007 A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.
17  TP53mut
(1 time)
Neoplasms
(1 time)
--- 2000 Raf-1 kinase activity predicts for paclitaxel resistance in TP53mut, but not TP53wt human ovarian cancer cells.
18  TP63, a p53
(1 time)
Molecular Biology
(1 time)
MFG-E8 (1 time)
TA (1 time)
2008 p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
19  transcription factor p53
(1 time)
Cell Biology
(1 time)
Cip1 (1 time)
2007 p18(Hamlet) mediates different p53-dependent responses to DNA-damage inducing agents.
20  transduced with a dominant negative p53
(1 time)
Genetics
(1 time)
--- 2007 Human glioblastoma U87MG cells transduced with a dominant negative p53 (TP53) adenovirus construct undergo radiation-induced mitotic catastrophe.
21  transformation-related protein 53
(1 time)
Respiratory Tract Diseases
(1 time)
COPD (1 time)
SNP (1 time)
SPDEF (1 time)
2018 Functional Studies of Single-Nucleotide Polymorphisms Suggest Heterogeneity in Chronic Obstructive Pulmonary Disease due to Susceptibility of Different Cell Types.
22  transgene for p53
(1 time)
Neoplasms
(1 time)
OV (1 time)
2017 Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.
23  TSGs, P53
(1 time)
Endocrinology
(1 time)
CCND1 (1 time)
PETs (1 time)
TSGs (1 time)
2012 Molecular pathology and genetics of pancreatic endocrine tumours.
24  Tumor P53 protein
(1 time)
Neoplasms
(1 time)
IHC (1 time)
2001 Ethnicity delineates different genetic pathways in malignant glioma.
25  tumor protein/suppressor p53
(1 time)
Biological Science Disciplines
(1 time)
MALDI-TOF MS (1 time)
PPARalpha (1 time)
2018 2D DIGE proteomic analysis reveals fasting-induced protein remodeling through organ-specific transcription factor(s) in mice.
26  Tumoral Protein p53
(1 time)
Medicine
(1 time)
EGFR (1 time)
KRAS (1 time)
2016 Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations.
27  wild-type p53
(1 time)
Science
(1 time)
LT (1 time)
MCCs (1 time)
MCV (1 time)
2019 Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
28  wild-type p53 protein
(1 time)
Gynecology
(1 time)
--- 2001 Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women.
29  wild-type tumour suppressor p53
(1 time)
Neoplasms
(1 time)
CAPOX (1 time)
KRAS (1 time)
2011 Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.